In a letter to the Centers for Medicare and Medicaid Services, the National Pharmaceutical Council (NPC) outlines some key issues with the agency's recently-proposed rule. NPC says the proposal "poses a barrier to implementing value-based arrangements and hinders innovation in payment and […]
Report Spotlights NPC’s Webinar on COVID-19 Prices
A recent report by The Pink Sheet spotlights the National Pharmaceutical Council's (NPC) recent meeting on COVID-19 drug prices. The webinar was held July 14, and included insights from: Peter B. Bach, MD, MAPP, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer […]
NPC Spotlights New NPC/Duke-Margolis Health Policy Fellow Salama Freed
A recent National Pharmaceutical Council blog post spotlights Salama Freed, the new NPC/Duke-Margolis Postdoctoral Health Policy fellow. Freed says she believes the fellowship will help bolster her understanding of health policy. "I want this research to actually turn into something," she […]
NPC Webinar on COVID-19 Prices Nears
The National Pharmaceutical Council's webinar on COVID-19 drug prices is less than a week away. Registration for the event remains open. "It's Time to Talk about COVID-19 Prices" is set for 3:30 p.m. EST July 14. Panelists include: Peter Bach, MD, MAPP, Director, Center for Health Policy […]
NPC, Duke-Margolis Center for Health Policy Name New Health Policy Fellow
The National Pharmaceutical Council (NPC) and Duke-Margolis Center for Health Policy recently named Salama Freed as the 2020-22 post-doctoral health policy fellow. According to a press release, the fellowship is "designed to bridge a persistent gap between health research and policy […]
NPC Plans Webinar in Prices for COVID-19 Drugs
An upcoming webinar hosted by the National Pharmaceutical Council (NPC) will discuss a range of pricing-related issues for COVID-19 drugs. The online event, set to begin 3:30 p.m. EST July 14, will offer key insights from a panel of industry experts. Panelists include: Peter Bach, MD, […]
NPC Blog Post Reflects on AMCP’s Format
The National Pharmaceutical Council (NPC) in a recent blog post reflects on the Academy of Managed Care Pharmacy's (AMCP) Format for Formulary Submissions, which marks its 20th anniversary this year. While the Format has made significant progress over 20 years, NPC says, there remain new […]
Dubois: It’s Time to Talk COVID-19 Prices
In a race to develop a vaccine for COVID-19, the biopharmaceutical industry has worked at "unheard-of speed," National Pharmaceutical Council CSO Robert Dubois writes in a recent Health Affairs blog post. With that, he writes, it's time to get a leg up on pricing discussions. "Fortunately, […]
Study Examines Value-Based Arrangements
A study published earlier this year in Value in Health explores the role of value-based arrangements in the U.S. health care system. The analysis was conducted by National Pharmaceutical Council's Robert Dubois, Kimberly Westrich and former research manager Lisabeth Buelt. To read NPC's blog […]
Research Considers Valuation of Indirect Benefits
The National Pharmaceutical Council (NPC) and RTI Health Solutions in research published earlier this year found the inclusion of indirect benefits to be low on the radar for payers, but of much higher importance to employer stakeholders. The study was published in the February issue of the […]
